Meeting
2019 Genitourinary Cancers Symposium
Obesity and metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials.
Authors
Alberto Martini
Icahn School of Medicine at Mount Sinai, New York, NY
Alberto Martini , Nikhil Waingankar , Nicholas M Brown , John P. Sfakianos , Ashutosh Tewari , Matthew Galsky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 287)
DOI
10.1200/JCO.2019.37.7_suppl.287
Abstract #
287
Poster Bd #
M22
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Associations between body mass index with cancer recurrence and all-cause mortality among survivors of breast cancer.
First Author: Po-Hua Chen
Poster
2020 ASCO Virtual Scientific Program
The association of fitness and body mass index (BMI) on all-cause mortality in cancer survivors: The Henry Ford Exercise Testing Project (The FIT Project).
First Author: Catherine Handy Marshall
Poster
2020 Genitourinary Cancers Symposium
Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data.
First Author: Anish B. Parikh
Poster
2016 Genitourinary Cancers Symposium
Prognostic role of body mass index (BMI) in patients with metastatic castration resistant prostate cancer (mCRPC) receiving chemotherapy: Preliminary results from a retrospective Italian multicenter study.
First Author: Stefania Eufemia Lutrino